These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 7530621

  • 21. Insulin-like growth factors and their binding proteins in children with IDDM.
    Wacharasindhu S, Srivuthana S, Aroonparkmongkol S.
    J Med Assoc Thai; 2002 Jan; 85(1):41-52. PubMed ID: 12075719
    [Abstract] [Full Text] [Related]

  • 22. Interleukin-6 (IL-6) and IGF-IGFBP system in children and adolescents with type 1 diabetes mellitus.
    Wedrychowicz A, Dziatkowiak H, Sztefko K, Wedrychowicz A.
    Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):435-9. PubMed ID: 15372363
    [Abstract] [Full Text] [Related]

  • 23. Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth.
    McIntyre HD, Serek R, Crane DI, Veveris-Lowe T, Parry A, Johnson S, Leung KC, Ho KK, Bougoussa M, Hennen G, Igout A, Chan FY, Cowley D, Cotterill A, Barnard R.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1143-50. PubMed ID: 10720053
    [Abstract] [Full Text] [Related]

  • 24. Is growth hormone hypersecretion in diabetic adolescent girls also a daytime problem?
    Halldin MU, Tylleskär K, Hagenäs L, Tuvemo T, Gustafsson J.
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):785-94. PubMed ID: 9713569
    [Abstract] [Full Text] [Related]

  • 25. Insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBP-1, -2 and -3) in diabetic pregnancy: relationship to macrosomia.
    Yan-Jun L, Tsushima T, Minei S, Sanaka M, Nagashima T, Yanagisawa K, Omori Y.
    Endocr J; 1996 Apr; 43(2):221-31. PubMed ID: 9026269
    [Abstract] [Full Text] [Related]

  • 26. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated.
    Näntö-Salonen K, Muller HL, Hoffman AR, Vu TH, Rosenfeld RG.
    Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799
    [Abstract] [Full Text] [Related]

  • 27. Insulin-like growth factors (IGF) I and II and IGF binding proteins 1, 2 and 3 during low-dose growth hormone (GH) infusion and sequential euglycemic and hypoglycemic glucose clamps: studies in GH-deficient patients.
    Jørgensen JO, Blum WF, Horn N, Møller N, Møller J, Ranke MB, Christiansen JS.
    Acta Endocrinol (Copenh); 1993 Jun; 128(6):513-20. PubMed ID: 7687807
    [Abstract] [Full Text] [Related]

  • 28. Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: age- and sex-related changes.
    Argente J, Barrios V, Pozo J, Muñoz MT, Hervás F, Stene M, Hernández M.
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1522-8. PubMed ID: 7505288
    [Abstract] [Full Text] [Related]

  • 29. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease.
    Donaghy A, Ross R, Gimson A, Hughes SC, Holly J, Williams R.
    Hepatology; 1995 Mar; 21(3):680-8. PubMed ID: 7533122
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of the components of insulin-like growth factor (IGF)-IGF binding protein (IGFBP) system in adolescents with type 1 diabetes and persistent microalbuminuria: relationship with increased urinary excretion of IGFBP-3 18 kD N-terminal fragment.
    Spagnoli A, Chiarelli F, Vorwerk P, Boscherini B, Rosenfeld RG.
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):587-96. PubMed ID: 10594519
    [Abstract] [Full Text] [Related]

  • 31. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.
    Clemmons DR, Moses AC, McKay MJ, Sommer A, Rosen DM, Ruckle J.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1518-24. PubMed ID: 10770191
    [Abstract] [Full Text] [Related]

  • 32. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis.
    Møller S, Juul A, Becker U, Flyvbjerg A, Skakkebaek NE, Henriksen JH.
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1148-57. PubMed ID: 7536200
    [Abstract] [Full Text] [Related]

  • 33. Growth and insulin-like growth factors (IGFs) in children with insulin-dependent diabetes mellitus at the onset of disease: evidence for normal growth, age dependency of the IGF system alterations, and presence of a small (approximately 18-kilodalton) IGF-binding protein-3 fragment in serum.
    Cianfarani S, Bonfanti R, Bitti ML, Germani D, Boemi S, Chiumello G, Boscherini B.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4162-7. PubMed ID: 11095448
    [Abstract] [Full Text] [Related]

  • 34. Serum insulin-like growth factor II levels in normal adolescents and those with insulin dependent diabetes mellitus.
    Acerini CL, Clayton KL, Hintz R, Baker B, Watts A, Holly JM, Dunger DB.
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):13-9. PubMed ID: 8796133
    [Abstract] [Full Text] [Related]

  • 35. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J, Urban M, Głowińska B, Urban B.
    Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
    [Abstract] [Full Text] [Related]

  • 36. Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients.
    Jørgensen JO, Blum WF, Møller N, Ranke MB, Christiansen JS.
    J Clin Endocrinol Metab; 1991 Mar; 72(3):582-7. PubMed ID: 1705258
    [Abstract] [Full Text] [Related]

  • 37. Use of the ligand immunofunctional assay for human insulin-like growth factor ((IGF) binding protein-3 (IGFBP-3) to analyze IGFBP-3 proteolysis and igf-i bioavailability in healthy adults, GH-deficient and acromegalic patients, and diabetics.
    Lassarre C, Duron F, Binoux M.
    J Clin Endocrinol Metab; 2001 May; 86(5):1942-52. PubMed ID: 11344189
    [Abstract] [Full Text] [Related]

  • 38. The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes.
    Hedman CA, Frystyk J, Fridell K, Jönsson A, Flyvbjerg A, Lindström T, Arnqvist HJ.
    Growth Horm IGF Res; 2005 Aug; 15(4):304-10. PubMed ID: 16054412
    [Abstract] [Full Text] [Related]

  • 39. The role of IGF-binding proteins in mediating the effects of recombinant human IGF-I on insulin requirements in type 1 diabetes mellitus.
    Crowne EC, Samra JS, Cheetham T, Acerini CL, Watts A, Holly JM, Dunger DB.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3686-91. PubMed ID: 11502796
    [Abstract] [Full Text] [Related]

  • 40. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.
    Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Müller J, Skakkebaek NE.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2534-42. PubMed ID: 7543116
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.